COVID-19 Breakthroughs: Dexamethasone, ECMO, and COVID-19 Clinical Trials

  • Jun 29, 2020
  • 12:00 PM

Dr. Steven J. O’Day, M.D., Executive Director of the John Wayne Cancer Institute and Cancer Clinic, and Director of Providence Los Angeles Regional Research, explains new advancements with Dexamethasone, ECMO treatment, and how our researches are adapting to find a vaccine for COVID-19.

Promising News in the Fight Against Coronavirus

  • Jun 16, 2020
  • 4:00 pm

Dr. Steven O’Day, M.D., was interviewed by the Los Angeles Times, CBS/KCAL and NBC, on a new British study that touts steroids as a breakthrough treatment for serious cases of COVID-19. Listen to Dr. O’Day discuss this new promising study.

Promising Steroid Treatment for Serious Cases of COVID-19

  • Jun 16, 2020
  • 3:00 pm

Promising Steroid Treatment for Serious Cases of COVID-19 CBSN Los Angeles interviewed Dr. Steven O’Day, M.D., Executive Director of the John…

Agenus NextGen CTLA-4 Antibody Data Presented at ASCO

  • May 31, 2020
  • 8:00 AM

Dr. Steven J. O’Day, M.D., presented Agenus NextGen CTLA-4 Antibody (AGEN1181) Data at the American Society of Clinical Oncology (ASCO) Virtual Scientific Program. Watch his poster presentation to learn about the data and how it’s benefiting a broad population of cancer patients.

Providence Saint John’s Medical Center in Santa Monica Participating in COVID-19 Clinical Trials

  • May 19, 2020
  • 11:00 AM

Dr. Steven O’Day, M.D., joined host Alex Cohen from Inside the Issue, Spectrum News 1, to discuss the cutting-edge COVID-19 clinical trials at the John Wayne Cancer Institute at Providence Saint John’s Health Center.

Activating Innate Immunity in Triple-Negative Breast Cancer and Other Tumors

  • May 11, 2020
  • 1:00 PM

Watch Steven J. O’Day, M.D., Executive Director of the John Wayne Cancer Institute and Cancer Clinic, and Director of Providence Los Angeles Regional Research, discusses the rationale for using Imprime PGG to trigger immunity and possibly enhance response to pembrolizumab in patients with metastatic triple-negative breast cancer.

Triple-Negative Breast Cancer: Clinical Benefit With Pembrolizumab Plus Imprime PGG

  • May 8, 2020
  • 1:00 PM

Steven J. O’Day, M.D., Executive Director of the John Wayne Cancer Institute and Cancer Clinic, and Director of Providence Los Angeles Regional Research, presented: Triple-Negative Breast Cancer: Clinical Benefit With Pembrolizumab Plus Imprime PGG at the AACR Annual Meeting. Watch his virtual presentation to learn the results.

Antiviral Drug Remdesivir Shows Promise For Treating Coronavirus

  • May 5, 2020
  • 1:00 PM

NBC4 interviewed Dr. Steven O’Day about the antiviral drug remdesivir and its preliminary data which shows hospitalized patients with COVID-19 who received remdesivir recovered faster than similar patients who received placebo. Watch the interview to learn more.

Lecture Presentation at Digestive Disease Week®

  • May 5, 2020
  • 10:15 AM - 10:30 AM

Dr. Mary Garland-Kledzik, Surgical Oncology Fellow at John Wayne Cancer Institute, will be presenting key findings at the Digestive Disease Week conference. Learn more about her presentation entitled: Prognostic Impact and Utility of Immunoprofiling in the Selection of Patients with Colorectal Peritoneal Carcinomatosis for Cytoreductive surgery and Heated Intraperitoneal Chemotherapy.

Coronavirus Clinical Trials and Promising Drugs Podcast

  • Apr 23, 2020
  • 7:00 am

Dr. Steven O’Day, M.D., joins host Christina Pascucci from KTLA5, to talk about some of the clinical trials that are taking place to combat COVID-19. Listen to the podcast to learn about some of the more promising drugs researchers are looking at that could get us closer to solving this crisis.